Epistaxis in Pregnant Women in the Covid-19 Era

Document Type : Original

Authors

1 Department of General surgery, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad

2 Department of Gynecology, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.

3 Department of Otolaryngology, College of Medicine, Al-Nahrain University, Baghdad, Iraq .

Abstract

Introduction:
Epistaxis is common throughout pregnancy and is usually not a cause for concern; severe nosebleeds are rare. An increased rate of nasal bleeding was observed during the COVID-19 epidemic.
 
Materials and Methods:
The study sample comprised 3,362 pregnant women who sought care at the Gynecologic and Obstetrics Department/ Al-Yarmouk Teaching Hospital and Al-Karkh Maternity Hospital between May 2020 and April 2021. All were asked to fill out a questionnaire.
 
Results:
Nine hundred forty-one pregnant women experienced an episode of epistaxis during the last pregnancy. One thousand seven hundred forty-eight pregnant women had a corona-positive history. Pregnant women with a positive history of coronavirus infection have a higher incidence of epistaxis (612 pregnant women) than pregnant women with a corona-negative history (329 pregnant women) P value (0.039%).
 
Conclusions:
Oxygen and blood-thinning drugs are the leading causes of the increased rate of nosebleeds among pregnant women during the Corona pandemic.

Keywords

Main Subjects

References

  1. Rosa E M, Alistair M I, Jameel M. Torrential epistaxis in the third trimester: a management conundrum. BMJ Case Rep 2014; 2014
  2. Dugan-K, Melissa MD., Connell, Sarah; Stika, Catherine MD, et al. Epistaxis of Pregnancy and Association with Postpartum Hemorrhage. journals.lww 2009; 114:1322-1325
  3. Giambanco L, Iannone V, Borriello M, Scibilia G, Scollo P. The way a nose could affect pregnancy: severe and recurrent epistaxis. Pan Afr Med J 2019; 34. 
  4. Piccioni MG, Derme M, Salerno L, Morrocchi E, Pecorini F, Porpora MG, et al. Management of severe epistaxis during pregnancy: a case report and review of the literature. Case Reports in Ob-Gyn 2019;1-3.
  5. World Health Organization. Novel Coronavirus-China". WHO 2020.
  6. World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". World Health Organization 2020
  7. Vittorio D, Massimo R, Antonio G, Marco d. Clinical recommendations for epistaxis management during the COVID-19 pandemic. Otolaryngol Head Neck Surg 2020; 163: 75–77.
  8. Poiroux L, Piquilloud L, Seegers V, Le Roy C, Colonval K, Agasse C, et al. Effect on comfort of administering bubble-humidified or dry Oxygen: The Oxyrea non-inferiority randomized study. Ann Intensive Care 2018; 8: 126.
  9. Miyamoto K, Nishimura M. Nasal dryness discomfort in individuals receiving dry Oxygen via nasal cannula. Respir Care 2008; 53: 503–504.
  10. Strumpf DA, Harrop P, Dobbin J, Richard P. Massive epistaxis from nasal CPAP therapy. Chest 1989; 95: 1141.
  11. Corrado L, Giacomo I, Luca C, Maurizio C, Paola F, Tim S et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. j. thromres 2020; 191: 9-14.
  12. Giacomo G, Marco C, Catalina C, Eugenio G, Ihab M, Alessandro G et al. COVID-19 infection and diffusion among the healthcare workforce in a large university-hospital in northwest Italy. Gli operatori sanitari con ruolo di coordinamento. Med Lav 2020; 111: 184-194.
  13. Hardy JJ, Connolly CM, Weir CJ. Epistaxis in pregnancy-not to be sniffed at. Int J Obstet Anesth 2008; 17:94-5.

 

 

Iranian Journal of Otorhinolaryngology
Volume 36, Issue 6
November and December 2024
Pages 669-674

Files

Share

How to cite

Statistics